menu
    • menu

    Company profile for Calluna Pharma

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Calluna Pharma, our focus is on pioneering therapies that aim to tackle chronic inflammation and fibrosis at their origins. Through an innovative therapeutic strategy, we target the upstream amplifiers of these diseases, providing potential applicability across a wide range of medical conditions. As a clinical-stage company, Calluna Pharma is dedicated to enhancing patient outcomes in areas where current treatments fall sho...
    At Calluna Pharma, our focus is on pioneering therapies that aim to tackle chronic inflammation and fibrosis at their origins. Through an innovative therapeutic strategy, we target the upstream amplifiers of these diseases, providing potential applicability across a wide range of medical conditions. As a clinical-stage company, Calluna Pharma is dedicated to enhancing patient outcomes in areas where current treatments fall short, underscoring our commitment to advancing healthcare solutions.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Calluna PharmaNorway Flag
    Country
    Country
    Norway
    Address
    Address
    Gaustadalléen 21, 0349 Oslo
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.callunapharma.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/callunapharma/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Calluna Pharma Appoints Gijs van den Brink as Director
    Calluna Pharma Appoints Gijs van den Brink as Director

    16 Dec 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-12-16/calluna-pharma-announces-the-appointment-of-gijs-van-den-brink-md-phd-as-independent-director

    PHARMIWEB
    16 Dec 2025
    Share Share
    Calluna Pharma Receives FDA Orphan Drug Designation For CAL101
    Calluna Pharma Receives FDA Orphan Drug Designation For CAL101

    31 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251031655764/en/Calluna-Pharma-Announces-U.S.-FDA-Orphan-Drug-Designation-Granted-to-CAL101-for-the-Treatment-of-Idiopathic-Pulmonary-Fibrosis-IPF

    BUSINESSWIRE
    31 Oct 2025
    Share Share
    Calluna Pharma Starts Phase 2 AURORA Study of CAL101
    Calluna Pharma Starts Phase 2 AURORA Study of CAL101

    26 Aug 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-08-26/calluna-pharma-announces-initiation-of-phase-2-aurora-study-of-cal101-for-idiopathic-pulmonary-fibro

    PHARMAWEB
    26 Aug 2025
    Share Share
    Calluna to Present Three Posters at 2025 ATS Conference
    Calluna to Present Three Posters at 2025 ATS Conference

    29 Apr 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250429817522/en/Calluna-Announces-Three-Poster-Presentations-at-the-2025-American-Thoracic-Society-International-Conference

    BUSINESSWIRE
    29 Apr 2025
    Share Share
    Calluna Pharma Completes Phase 1 Study of CAL101
    Calluna Pharma Completes Phase 1 Study of CAL101

    23 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241023939388/en

    BUSINESSWIRE
    23 Oct 2024
    Share Share
    Calluna Pharma Names CEO
    Calluna Pharma Names CEO

    09 Oct 2024

    // CONTRACT PHARMA

    https://www.contractpharma.com//contents/view_breaking-news/2024-10-09/calluna-pharma-names-ceo/?widget=listSection

    CONTRACT PHARMA
    09 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search